Literature DB >> 2119557

Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans.

P Marteau1, P Pochart, B Flourié, P Pellier, L Santos, J F Desjeux, J C Rambaud.   

Abstract

Nine healthy volunteers were studied before, during, and after ingesting a fermented dairy product containing Lactobacillus acidophilus, Bifidobacterium bifidum, and mesophilic cultures (Streptococcus lactis and S cremoris) for 3 wk. Hydrogen and methane productions and fecal beta-galactosidase and beta-glucosidase activities were measured as indicators of fermentation capacity of the colonic flora. Fecal concentrations of nitroreductase, azoreductase, and beta-glucuronidase, which may be implicated in colonic carcinogenesis, were also assessed. Hydrogen and methane productions, fecal beta-galactosidase, beta-glucuronidase, and azoreductase activities did not change over three 3-wk periods whereas fecal beta-glucosidase activity increased (42 +/- 6, 91 +/- 12, and 40 +/- 6 IU/g N, P less than 0.01) and nitroreductase decreased (0.87 +/- 0.13, 0.54 +/- 0.11, and 0.57 +/- 0.08 IU/g N, P less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119557     DOI: 10.1093/ajcn/52.4.685

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  26 in total

1.  Probiotics and functional foods in gastrointestinal disorders.

Authors:  M H Floch; J Hong-Curtiss
Journal:  Curr Gastroenterol Rep       Date:  2001-08

Review 2.  Functional analysis of colonic bacterial metabolism: relevant to health?

Authors:  Henrike M Hamer; Vicky De Preter; Karen Windey; Kristin Verbeke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-20       Impact factor: 4.052

3.  Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men.

Authors:  Ellen G H M van den Heuvel; Daniel Wils; Wilrike J Pasman; Marie-Hélène Saniez; Alwine F M Kardinaal
Journal:  Eur J Nutr       Date:  2005-02-09       Impact factor: 5.614

Review 4.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

Review 5.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

6.  The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo.

Authors:  M F Bernet-Camard; V Liévin; D Brassart; J R Neeser; A L Servin; S Hudault
Journal:  Appl Environ Microbiol       Date:  1997-07       Impact factor: 4.792

7.  Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?

Authors:  F Briet; P Pochart; P Marteau; B Flourie; E Arrigoni; J C Rambaud
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

Review 8.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

9.  Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing.

Authors:  Tao Niu; Diane L Smith; Zhen Yang; Song Gao; Taijun Yin; Zhi-Hong Jiang; Ming You; Richard A Gibbs; Joseph F Petrosino; Ming Hu
Journal:  Pharm Res       Date:  2012-12-20       Impact factor: 4.200

10.  Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content.

Authors:  Do Kyung Lee; Seok Jang; Eun Hye Baek; Mi Jin Kim; Kyung Soon Lee; Hea Soon Shin; Myung Jun Chung; Jin Eung Kim; Kang Oh Lee; Nam Joo Ha
Journal:  Lipids Health Dis       Date:  2009-06-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.